MIM
LIN icon

MetLife Investment Management’s Linde LIN Stock Holding History

MetLife Investment Management’s Portfolio LIN Stock Details LIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.9M Sell
105,758
-3,395
-3% -$1.72M 0.25% 57
2026
Q1 		$54.1M Sell
109,153
-2,831
-3% -$1.34M 0.28% 44
2025
Q4 		$47.7M Sell
111,984
-4,375
-4% -$1.87M 0.23% 61
2025
Q3 		$55.3M Sell
116,359
-3,569
-3% -$1.69M 0.27% 47
2025
Q2 		$56.3M Sell
119,928
-3,828
-3% -$1.75M 0.33% 39
2025
Q1 		$57.6M Sell
123,756
-2,354
-2% -$1.06M 0.31% 41
2024
Q4 		$52.8M Buy
126,110
+1,110
+0.9% +$506K 0.29% 45
2024
Q3 		$59.6M Sell
125,000
-3,221
-3% -$1.47M 0.34% 36
2024
Q2 		$56.3M Buy
128,221
+12,801
+11% +$5.63M 0.33% 39
2024
Q1 		$53.6M Sell
115,420
-4,169
-3% -$1.81M 0.36% 36
2023
Q4 		$49.1M Sell
119,589
-3,081
-3% -$1.21M 0.35% 40
2023
Q3 		$45.7M Sell
122,670
-3,544
-3% -$1.35M 0.36% 38
2023
Q2 		$48.1M Sell
126,214
-5,075
-4% -$1.85M 0.35% 42
2023
Q1 		$46.7M Sell
131,289
-1,959
-1% -$656K 0.34% 40
2022
Q4 		$43.5M Sell
133,248
-3,508
-3% -$1.1M 0.33% 40
2022
Q3 		$36.9M Sell
136,756
-3,138
-2% -$901K 0.31% 49
2022
Q2 		$40.2M Buy
139,894
+10,686
+8% +$3.34M 0.31% 54
2022
Q1 		$41.3M Buy
129,208
+15,963
+14% +$4.94M 0.27% 63
2021
Q4 		$39.2M Sell
113,245
-3,392
-3% -$1.1M 0.32% 55
2021
Q3 		$34.2M Sell
116,637
-3,971
-3% -$1.21M 0.31% 54
2021
Q2 		$34.9M Sell
120,608
-3,984
-3% -$1.16M 0.31% 58
2021
Q1 		$34.9M Sell
124,592
-2,872
-2% -$745K 0.32% 56
2020
Q4 		$33.6M Sell
127,464
-5,738
-4% -$1.41M 0.32% 54
2020
Q3 		$31.7M Sell
133,202
-4,154
-3% -$1.01M 0.35% 54
2020
Q2 		$29.1M Sell
137,356
-1,108
-0.8% -$214K 0.33% 54
2020
Q1 		$24M Sell
138,464
-4,237
-3% -$836K 0.33% 61
2019
Q4 		$30.4M Sell
142,701
-4,414
-3% -$889K 0.32% 61
2019
Q3 		$28.5M Sell
147,115
-2,493
-2% -$483K 0.31% 61
2019
Q2 		$30M Sell
149,608
-7,037
-4% -$1.32M 0.32% 55
2019
Q1 		$27.6M Buy
+156,645
New +$26M 0.08% 185

Other funds holding LIN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MetLife Investment Management's LIN Position: Q2 2026 in Review

MetLife Investment Management reduced its Linde (LIN) stake by 3.1% in Q2 2026, selling an estimated $1.72M and leaving 105,758 shares worth $54.9M. The position accounts for 0.25% of the portfolio, ranked #57.

MetLife Investment Management first reported a position in LIN in Q1 2019 and has held it in 30 quarters since. The position peaked at $59.6M in Q3 2024. 2,341 funds tracked by Wall St. Rank hold LIN as of Q2 2026.

  • MetLife Investment Management held 105,758 shares of Linde worth $54.9M as of Q2 2026.
  • MetLife Investment Management sold 3,395 Linde shares in Q2 2026, an estimated $1.72M.
  • Linde made up 0.25% of MetLife Investment Management's portfolio in Q2 2026, its #57 holding.
  • MetLife Investment Management first reported a position in Linde in Q1 2019 and has held it in 30 quarters since.
  • MetLife Investment Management's Linde position peaked at $59.6M in Q3 2024.
  • 2,341 funds tracked by Wall St. Rank held Linde as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.